Regional Treatment Strategies for In-Transit Melanoma Metastasis
- 1 January 2011
- journal article
- review article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 20 (1) , 79-103
Abstract
No abstract availableKeywords
This publication has 145 references indexed in Scilit:
- Tyrosine Phosphorylation of the Human Glutathione S-Transferase P1 by Epidermal Growth Factor ReceptorJournal of Biological Chemistry, 2009
- A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the USJournal of the American College of Surgeons, 2009
- Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanomaCancer, 2008
- CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitProceedings of the National Academy of Sciences, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerNew England Journal of Medicine, 2007
- Long-term Results of Hyperthermic, Isolated Limb Perfusion for MelanomaAnnals of Surgery, 2007
- Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysisBritish Journal of Cancer, 2006
- Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in ScandinaviaInternational Journal of Cancer, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002